AstraZeneca headquarters: Why is the AstraZeneca vaccine made in India?

Aside from the UK, the SII has made similar arrangements with countries like Saudi Arabia and South Africa.

In addition, the Indian Pharma manufacturer has pledged to supply 240million AstraZeneca doses to the World Health Organisation’s equitable distribution scheme, Covax, during the first half of 2021.

But while the delay in vaccination comes as a surprise to some, those who have been closely monitoring the situation likely saw it coming.

The SII’s CEO, Adar Poonawalla, warned of potential shortages and delays back in February.

source: express.co.uk